Palatin Technologies
PTN
#10620
Rank
A$21.91 M
Marketcap
A$12.32
Share price
1.65%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -A$9.22 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$12.88 Million. In 2025 the company made an earning of -A$13.75 Million, an increase over its 2024 earnings that were of -A$38.5 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$9.22 Million-32.94%
2025 -A$13.75 Million-64.29%
2024 -A$38.5 Million-16.9%
2023 -A$46.33 Million5.99%
2022 -A$43.72 Million-13.7%
2021 -A$50.65 Million33.25%
2020 -A$38.01 Million-172.11%
2019 A$52.7 M2352.33%
2018 A$2.14 M-94.13%
2017 A$36.62 M-154.92%
2016 -A$66.69 Million3.67%
2015 -A$64.33 Million878%
2014 -A$6.58 Million-72.64%
2013 -A$24.04 Million-33.11%
2012 -A$35.94 Million77.71%
2011 -A$20.23 Million
2003 -A$34.25 Million29.93%
2002 -A$26.36 Million36.18%
2001 -A$19.36 Million
1999 -A$16.07 Million6.04%
1998 -A$15.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.12 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.95 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.14 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$16.75 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.27 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.16 B-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$42.14 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$82.81 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA